Evaluation of RC28-E Injection in Diabetic Macular Edema

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
This is a non-randomized, open-label, multicenter, 48-week study to investigate the efficacy, safety and pharmacokinetics of RC28-E injection in the treatment of patients with diabetic macular edema.
Epistemonikos ID: d666fcd708adf9f136abec0ad405e028400ffdb5
First added on: May 08, 2024